KTC
IHE icon

Kistler-Tiffany Companies’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Kistler-Tiffany Companies’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-264
Closed -$12K – 519
2016
Q4 		$12K Buy
+264
New +$12.5K 0.01% 401
2015
Q3 		– Sell
-1,170
Closed -$68K – 611
2015
Q2 		$68K Buy
+1,170
New +$68.3K 0.04% 221

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Kistler-Tiffany Companies's IHE Position: Q1 2017 in Review

Kistler-Tiffany Companies sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2017, closing a stake of 264 shares — an estimated $12K sold.

Kistler-Tiffany Companies first reported a position in IHE in Q2 2015 and held it in 2 quarters. The position peaked at $68K in Q2 2015. 97 funds tracked by Wall St. Rank hold IHE as of Q1 2017.

  • Kistler-Tiffany Companies reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 264 iShares US Pharmaceuticals ETF shares in Q1 2017, an estimated $12K.
  • Kistler-Tiffany Companies first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and held it in 2 quarters.
  • Kistler-Tiffany Companies's iShares US Pharmaceuticals ETF position peaked at $68K in Q2 2015.
  • 97 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2017.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2017, filed 4 May 2017.